检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王梦豪 张晓丹[1] 杨慰[1] 余思思[1] 蔡艳[1] 李家英 WANG Meng-hao;ZHANG Xiao-dan;YANG Wei;YU Si-si;CAI Yan;LI Jia-ying(Demonstration Center for Traditional Medicine,The Seventh People’s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200137,China)
机构地区:[1]上海中医药大学附属第七人民医院传统医学示范中心,上海200137
出 处:《中成药》2024年第4期1168-1172,共5页Chinese Traditional Patent Medicine
基 金:上海市科学技术委员会“扬帆计划”项目(20YF1437000);“浦东新区国家中医药发展综合改革试验区”叶玉妹浦东中医名家工作室项目(PDZY-2021-1005);上海中医药大学“杏林百人”计划项目(上中医人字[2020] 23号)。
摘 要:目的 考察丹篓片联合阿托伐他汀钙片对痰瘀互结证稳定性心绞痛患者的临床疗效。方法 80例患者随机分为对照组和观察组,每组40例,对照组给予阿托伐他汀钙片,观察组在对照组基础上加用丹篓片,疗程8周。检测临床疗效、中医证候评分、血管内皮功能指标(NO、VEGF、ET-1)、血脂相关指标(TC、TG、HDL-C、LDL-C、脂蛋白a、ApoB/A1)、24 h动态心电图指标(缺血发作次数、最长持续时间、心脏缺血总负荷)、SAQ评分、安全性指标(AST、ALT、Scr、BUN)变化。结果 观察组总有效率高于对照组(P<0.05)。治疗后,2组中医证候评分、ET-1、TC、TG、LDL-C、脂蛋白a、ApoB/A1、24 h动态心电图指标降低(P<0.05),NO、VEGF、HDL-C、SAQ评分升高(P<0.05),以观察组更明显(P<0.05)。2组安全性指标比较,差异无统计学意义(P>0.05)。结论 丹篓片联合阿托伐他汀钙片可安全有效地改善痰瘀互结证稳定性心绞痛患者心肌缺血程度、临床症状,调节血脂,减轻血管内皮损伤。AIM To investigate the clinical effects of Danlou Tablets combined with Atorvastatin Calcium Tablets on patients with stable angina pectoris of Intermingled Phlegm and Blood Stasis Pattern.METHODS Eighty patients were randomly assigned into the control group(40 cases)for 8-week administration of Atorvastatin Calcium Tablets,and observation group(40 cases)for 8-week administration of both Danlou Tablets and Atorvastatin Calcium Tablets.The changes in clinical efficacy,TCM syndrome scores,vascular endothelial function indices(NO,VEGF,ET-1),lipid-related indices(TC,TG,HDL-C,LDL-C,lipoprotein a,ApoB/A1),24 h dynamic electrocardiogram indices(ischemic attack number,longest duration,total cardiac ischemia load),SAQ score and safety indices(AST,ALT,Scr,BUN)were detected.RESULTS The observation group demonstrated higher total effective rate than the control group(P<0.05).After the treatment,the two groups displayed decreased TCM syndrome scores,ET-1,TC,TG,LDL-C,lipoprotein a,ApoB/A1,24 h dynamic electrocardiogram indices(P<0.05),and increased NO,VEGF,HDL-C,SAQ score(P<0.05),especially for the observation group(P<0.05).CONCLUSION For the patients with stable angina pectoris due to Binding of Phlegm and Blood Stasis,Danlou Tablets combined with Atorvastatin Calcium Tablets can safely and effectively improve myocardial ischemia degree and clinical symptoms,regulate blood lipids,and alleviate vascular endothelial damage.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.119.110.206